Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemiaMarina Konopleva, Hagop Kantarjian, Peter F. Thall et al.|Haematologica|2015Cited by 121
DNA Cross-Links in Human Tumor Cells Exposed to the Prodrug PR-104A: Relationships to Hypoxia, Bioreductive Metabolism, and CytotoxicityRachelle S. Singleton, William R. Wilson|Cancer Research|2009Cited by 83
Functional CRISPR and shRNA Screens Identify Involvement of Mitochondrial Electron Transport in the Activation of EvofosfamideFrancis W. Hunter, William R. Wilson, Troy Ketela et al.|Molecular Pharmacology|2019Cited by 19